Concepedia

MyLinh T. Duong

MT

Statistics

Publications

4

Citations

308

H-Index

4

Active since

2012

Affiliations

Bellicum Pharmaceuticals (United States)(Current)

MyLinh T. Duong is an author at Bellicum Pharmaceuticals (United States) specializing in immunology, cancer immunotherapy, and oncology.

Publications per year

2012–2019

4

Publications

4

Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40

Aaron E. Foster, Aruna Mahendravada, Nicholas Shinners et al. · Molecular Therapy · 2017 · 106 citations · Full text

, , +17

Two-Dimensional Regulation of CAR-T Cell Therapy with Orthogonal Switches

MyLinh T. Duong, Matthew R. Collinson-Pautz, Éva Morschl et al. · Molecular Therapy — Oncolytics · 2018 · 83 citations · Full text

, , +17

Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignancies

Matthew R. Collinson-Pautz, Wei-Chun Chang, An Lu et al. · Leukemia · 2019 · 80 citations · Full text

, , +17

LMW-E/CDK2 Deregulates Acinar Morphogenesis, Induces Tumorigenesis, and Associates with the Activated b-Raf-ERK1/2-mTOR Pathway in Breast Cancer Patients

MyLinh T. Duong, Saïd Akli, Caimiao Wei et al. · PLoS Genetics · 2012 · 39 citations · Full text

, , +17

1–4 of 4